Search results for "CACO-2"

showing 10 items of 203 documents

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Piroxicam

2014

ABSTRACT Literature and experimental data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing piroxicam in the free acid form are reviewed. Piroxicam solubility and permeability, its therapeutic use and therapeutic index, pharmacokinetic properties, data related to the possibility of excipient interactions and reported BE/bioavailability (BA), and corresponding dissolution data are taken into consideration. The available data suggest that according to the current biopharmaceutics classification system (BCS) and all current guidances, piroxicam would be assigned to BCS Class II. The ex…

DrugChemistry Pharmaceuticalmedia_common.quotation_subjectBiological AvailabilityPharmaceutical ScienceExcipientBioequivalencePharmacologyPiroxicamDosage formBiopharmaceuticsArthritis RheumatoidExcipientsFood-Drug InteractionsPiroxicamPharmacokineticsmedicineAnimalsHumansTissue Distributionmedia_commonChemistryAnti-Inflammatory Agents Non-SteroidalStereoisomerismBiopharmaceutics Classification SystemRatsBioavailabilityIntestinal AbsorptionSolubilityTherapeutic EquivalencyCaco-2 CellsHalf-Lifemedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Biowaiver monograph for immediate-release solid oral dosage forms: acetylsalicylic acid.

2012

A biowaiver monograph for acetylsalicylic acid (ASA) is presented. Literature and experimental data indicate that ASA is a highly soluble and highly permeable drug, leading to assignment of this active pharmaceutical ingredient (API) to Class I of the Biopharmaceutics Classification System (BCS). Limited bioequivalence (BE) studies reported in the literature indicate that products that have been tested are bioequivalent. Most of the excipients used in products with a marketing authorization in Europe are not considered to have an impact on gastrointestinal motility or permeability. Furthermore, ASA has a wide therapeutic index. Thus, the risks to the patient that might occur if a nonbioequi…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological AvailabilityPharmacologyBioequivalenceMarketing authorizationDosage formDrug StabilityFibrinolytic AgentsAnimalsHumansCyclooxygenase Inhibitorsmedia_commonActive ingredientAspirinChemistryAnti-Inflammatory Agents Non-SteroidalBiopharmaceutics Classification SystemSolubilityTherapeutic EquivalencyPlatelet aggregation inhibitorCaco-2 CellsFibrinolytic agentPlatelet Aggregation InhibitorsTabletsJournal of pharmaceutical sciences
researchProduct

Echovirus 1 Entry into Polarized Caco-2 Cells Depends on Dynamin, Cholesterol, and Cellular Factors Associated with Macropinocytosis

2013

ABSTRACT Enteroviruses invade their hosts by crossing the intestinal epithelium. We have examined the mechanism by which echovirus 1 (EV1) enters polarized intestinal epithelial cells (Caco-2). Virus binds to VLA-2 on the apical cell surface and moves rapidly to early endosomes. Using inhibitory drugs, dominant negative mutants, and small interfering RNAs (siRNAs) to block specific endocytic pathways, we found that virus entry requires dynamin GTPase and membrane cholesterol but is independent of both clathrin- and caveolin-mediated endocytosis. Instead, infection requires factors commonly associated with macropinocytosis, including amiloride-sensitive Na + /H + exchange, protein kinase C, …

DynaminsSodium-Hydrogen ExchangersEndosomeImmunologyEndocytic cycleEndocytosisMicrobiologyClathrinViral entryVirologyHumansTransport VesiclesProtein Kinase CDynaminbiologyPinocytosisEpithelial CellsVirus InternalizationIntestinal epitheliumEnterovirus B HumanVirus-Cell InteractionsCell biologyDNA-Binding ProteinsAlcohol OxidoreductasesCholesterolInsect ScienceHost-Pathogen Interactionsbiology.proteinPinocytosisCaco-2 CellsJournal of Virology
researchProduct

Polymeric microcontainers improve oral bioavailability of furosemide.

2016

Microcontainers with an inner diameter of 223 μm are fabricated using the polymer SU-8, and evaluated in vitro, in situ and in vivo for their application as an advanced oral drug delivery system for the poorly water soluble drug furosemide. An amorphous sodium salt of furosemide (ASSF) is filled into the microcontainers followed by applying a lid using Eudragit L100. It is possible to control the drug release in vitro, and in vitro absorption studies show that the microcontainers are not a hindrance for absorption of ASSF. In situ perfusion studies in rats are performed with ASSF-filled microcontainers coated with Eudragit and compared to a furosemide solution. The absorption rate constant …

Eudragit l100PolymersPharmaceutical ScienceAdministration OralBiological Availability02 engineering and technologyAbsorption (skin)PharmacologyMicro devices030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineDrug Delivery SystemsPolymethacrylic AcidsIn vivoDelivery systemsFurosemideOral bioavailabilitymedicineAnimalsHumansIntestinal MucosaRats WistarIntestinal mucusChromatographyChemistryFurosemide021001 nanoscience & nanotechnologyBioavailabilityDrug LiberationMucusOral deliveryEpoxy CompoundsFemaleDelivery systemIntestinal perfusionCaco-2 Cells0210 nano-technologyOral retinoidmedicine.drugInternational journal of pharmaceutics
researchProduct

In-vitro antioxidant capacity and cytoprotective/cytotoxic effects upon Caco-2 cells of red tilapia (Oreochromis spp.) viscera hydrolysates.

2019

Abstract The antioxidant capacity of red tilapia viscera hydrolysates (RTVH) with different degrees of hydrolysis (DH) as well as their ultrafiltration membrane fractions, were analyzed using different chemical assays. Their protective effects against oxidative stress were evaluated using H2O2-stressed human intestinal differentiated Caco-2. The highest antioxidant capacity was obtained with a DH of 42.5% (RTVH-A) and its

Fish Proteinsfood.ingredient030309 nutrition & dieteticsCell SurvivalProtein HydrolysatesUltrafiltrationmedicine.disease_causeHydrolysateAntioxidants03 medical and health sciencesHydrolysis0404 agricultural biotechnologyfoodFunctional FoodmedicineAnimalsHumansFood science0303 health sciencesbiologyChemistryHydrolysisCell CycleTilapia04 agricultural and veterinary sciencesbiology.organism_classification040401 food scienceGlutathioneIn vitroIntestinesOreochromisOxidative StressVisceraCaco-2Caco-2 CellsReactive Oxygen SpeciesOxidative stressFood ScienceTilapiaFood research international (Ottawa, Ont.)
researchProduct

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates.

2004

Abstract The pharmacokinetics of antipsychotic drugs has become an integral part in understanding their pharmacodynamic activity and clinical effects. In addition to metabolism aspects, carrier-mediated transport, particularly secretion by ABC transporters, has been discussed as potentially relevant for this group of therapeutics. In this study, the psychoactive compounds perphenazine, flupentixol, domperidone, desmethyl clozapine, haloperidol, fluphenazine, fluvoxamine, olanzapine, levome-promazine, perazine, desmethyl perazine, clozapine, quetiapine and amisulpride were characterized in terms of P-glycoprotein (P-gp) affinity and transport. Experimental methods involved a radioligand disp…

FluphenazineMalePerphenazineATP Binding Cassette Transporter Subfamily BPharmaceutical SciencePharmacologySubstrate Specificitychemistry.chemical_compoundPharmacokineticsmedicineFluphenazineAnimalsHumansDrug InteractionsTissue DistributionAmisulprideClozapinePharmacologyBrainPerazineFlupentixolRatschemistryCyclosporineAmisulprideCaco-2 CellsSulpirideImmunosuppressive Agentsmedicine.drugTalinololAntipsychotic AgentsThe Journal of pharmacy and pharmacology
researchProduct

Lemon Juice, Sesame Paste, and Autoclaving Influence Iron Bioavailability of Hummus: Assessment by an In Vitro Digestion/Caco-2 Cell Model

2020

Hummus, an iron-containing plant-based dish mainly made from chickpea pur&eacute

Food processing and formulationHealth (social science)030309 nutrition & dieteticsIron uptake by Caco-2 cellsPlant Sciencelcsh:Chemical technologyHealth Professions (miscellaneous)MicrobiologyArticlelaw.invention03 medical and health sciences0404 agricultural biotechnologyIron dialysisPlant-based foodIn vivolaw[SDV.IDA]Life Sciences [q-bio]/Food engineeringlcsh:TP1-1185Food science2. Zero hunger0303 health sciencesbiologyChemistryMediterranean and middle-eastern cuisineCell modelIn vitro digestion04 agricultural and veterinary sciences[SDV.IDA] Life Sciences [q-bio]/Food engineeringIn vitro digestionHummus040401 food science3. Good healthBioavailabilityFerritin[SDV.AEN] Life Sciences [q-bio]/Food and NutritionCaco-2biology.proteinLemon juiceAtomic absorption spectroscopy[SDV.AEN]Life Sciences [q-bio]/Food and NutritionNon-heme ironFood Science
researchProduct

Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters.

2003

Psoriasis is a chronic inflammatory skin disease. Its treatment is based on the inhibition of proliferation of epidermal cells and interference in the inflammatory process. A new systemic antipsoriasis drug, which consists of dimethylfumarate and ethylhydrogenfumarate in the form of their calcium, magnesium and zinc salts has been introduced in Europe with successful results. In the present study, a homologous series of mono- and diesters of fumaric acid has been studied with respect to the sites and kinetics of presystemic ester degradation using pancreas extract, intestinal perfusate, intestinal homogenate and liver S9 fraction. In addition, intestinal permeability has been determined usi…

Fumaric acidCell Membrane PermeabilitySwineDimethyl FumaratePharmaceutical ScienceBiological AvailabilityPancreatic ExtractsIntestinal absorptionchemistry.chemical_compoundIntestinal mucosaFumaratesmedicineAnimalsHumansPsoriasisPharmacology (medical)Enzyme InhibitorsIntestinal MucosaCells CulturedPharmacologyIntestinal permeabilityDimethyl fumarateMicrovilliGeneral MedicineMetabolismmedicine.diseasePropranololIntestineschemistryBiochemistryS9 fractionAtenololIntestinal AbsorptionLipophilicityCaco-2 CellsLiver ExtractsBiopharmaceuticsdrug disposition
researchProduct

Study of the potential toxicity of commercial crispy breads by evaluation of bioaccessibility and bioavailability of minor Fusarium mycotoxins

2011

Abstract Enniatins (ENs) are bioactive compounds produced by the secondary metabolism of several Fusarium strains and known to have several biological activities, such as acting as enzyme inhibitors, antifungal and antibacterial agents, and immunomodulatory substances. This study has investigated the ENs bioaccessibility, spiked in commercial wheat crispy bread at 1.5 and 3.0 μmol/g concentrations, their transepithelial transport and bioavailability using Caco-2 cells as a model of the human intestinal epithelium. The content (%) of the four ENs contained in the gastric fluid has resulted variable from 69% to 91%, considering the two concentrations assayed. The mean bioaccessibility data fo…

FusariumBiological AvailabilityFood ContaminationAbsorption (skin)Toxicologychemistry.chemical_compoundFusariumDepsipeptidesHumansFood scienceSecondary metabolismMycotoxinTriticumchemistry.chemical_classificationbiologyGastric fluidBiological TransportBreadGeneral MedicineMycotoxinsbiology.organism_classificationBioavailabilityEnzymechemistryEnvironmental chemistryCaco-2 CellsFood SciencePotential toxicityFood and Chemical Toxicology
researchProduct

Study of the potential toxicity of enniatins A, A(1), B, B(1) by evaluation of duodenal and colonic bioavailability applying an in vitro method by Ca…

2010

Abstract The bioavailability of the minor Fusarium mycotoxins enniatins (ENs) utilizing an in vitro method which allows the simulation of the small and large intestine tracts has been studied. This method, based on the application of the Caco-2 cells grown alone or in symbiosis with several strains characteristics of the gastrointestinal tract, has permitted to simulate the duodenal and colonic intestinal compartments, respectively. The duodenal bioavailability expressed as absorption value after 4 h of exposure, ranged from 57.7 to 76.8% for EN A, from 68.8 to 70.2% for EN A1, from 65.0 to 67.0% for EN B, and from 62.2 to 65.1% for EN B1. Colonic bioavailability after 48 h of incubation ra…

FusariumColonDuodenumBiological AvailabilityAbsorption (skin)PharmacologyToxicologyRisk AssessmentFusariumDepsipeptidesToxicity TestsmedicineHumansLarge intestineIncubationGastrointestinal tractbiologyChemistryMycotoxinsbiology.organism_classificationIn vitroBioavailabilitymedicine.anatomical_structureIntestinal AbsorptionCaco-2Caco-2 CellsToxicon : official journal of the International Society on Toxinology
researchProduct